Amlodipine and Valsartan Tablets 10 mg/160 mg, (a) 30-count bottles (NDC 0093-7961-56) & 90-count...

FDA Recall #D-0304-2019 — Class II — November 27, 2018

Recall #D-0304-2019 Date: November 27, 2018 Classification: Class II Status: Ongoing

Product Description

Amlodipine and Valsartan Tablets 10 mg/160 mg, (a) 30-count bottles (NDC 0093-7961-56) & 90-count bottles (NDC 0093-7691-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.

Reason for Recall

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Recalling Firm

Teva Pharmaceuticals USA — North Wales, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

39,617 bottles

Distribution

USA Nationwide including Puerto Rico.

Code Information

NDC 0093-7691-56 & NDC 0093-7691-98 Lot # 24X012, 24X013

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated